Статьи

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
European Heart Journal Advance Access published February 18, 2015.
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
European Heart Journal (2017).
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
European Heart Journal (2016).
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза.
Российские рекомендации VI пересмотр. Москва 2017 год.